Aim The coronavirus disease (COVID)‐19 incidence was higher in diabetes mellitus (DM), although several differences should be considered on the basis of characteristics of cohorts evaluated. This study was designed to evaluate the prevalence and potential consequences of COVID-19 in a large diabetic population in Northern Italy. Design Observational, longitudinal, retrospective, clinical study. Methods Subjects with both type 1 and type 2 DM living in the Province of Modena and submitted to at least one SARSCoV- 2 swab between March 2020 and March 2021 were included. Data were extracted from the Hospital data warehouse. Results 9553 diabetic subjects were enrolled (age 68.8 ± 14.1 years, diabetes duration 11.0 ± 6.9 years, glycated hemoglobin 57.2 ± 16.2 mmol/mol). COVID-19 was detected in 2302 patients (24.1%) with a death rate of 8.9%. The mean age and diabetes duration were significantly lower in infected versus non-infected patients. SARS-CoV-2 infection was more frequent in youngest people, according to quartile of age and retirement pension age of 65 years. No differences were detected considering sex. Higher HbA1c was detected in infected compared to non-infected patient. Death was predicted by diabetes duration and HbA1c. ROC analyses for death risk showed significant threshold for diabetes duration (10.9 years) and age (74.4 years). Conclusion In our cohort, SARS-CoV-2 infection correlates with age, diabetes duration and disease control. Diabetic patients

Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects / Greco, Carla; Pirotti, Tommaso; Brigante, Giulia; Filippini, Tommaso; Pacchioni, Chiara; Trenti, Tommaso; Simoni, Manuela; Santi, Daniele. - In: ACTA DIABETOLOGICA. - ISSN 0940-5429. - 60:6(2023), pp. 817-825. [10.1007/s00592-023-02073-4]

Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects.

Greco Carla
;
Pirotti Tommaso;Brigante Giulia;Filippini Tommaso;Simoni Manuela;Santi Daniele
2023

Abstract

Aim The coronavirus disease (COVID)‐19 incidence was higher in diabetes mellitus (DM), although several differences should be considered on the basis of characteristics of cohorts evaluated. This study was designed to evaluate the prevalence and potential consequences of COVID-19 in a large diabetic population in Northern Italy. Design Observational, longitudinal, retrospective, clinical study. Methods Subjects with both type 1 and type 2 DM living in the Province of Modena and submitted to at least one SARSCoV- 2 swab between March 2020 and March 2021 were included. Data were extracted from the Hospital data warehouse. Results 9553 diabetic subjects were enrolled (age 68.8 ± 14.1 years, diabetes duration 11.0 ± 6.9 years, glycated hemoglobin 57.2 ± 16.2 mmol/mol). COVID-19 was detected in 2302 patients (24.1%) with a death rate of 8.9%. The mean age and diabetes duration were significantly lower in infected versus non-infected patients. SARS-CoV-2 infection was more frequent in youngest people, according to quartile of age and retirement pension age of 65 years. No differences were detected considering sex. Higher HbA1c was detected in infected compared to non-infected patient. Death was predicted by diabetes duration and HbA1c. ROC analyses for death risk showed significant threshold for diabetes duration (10.9 years) and age (74.4 years). Conclusion In our cohort, SARS-CoV-2 infection correlates with age, diabetes duration and disease control. Diabetic patients
2023
60
6
817
825
Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects / Greco, Carla; Pirotti, Tommaso; Brigante, Giulia; Filippini, Tommaso; Pacchioni, Chiara; Trenti, Tommaso; Simoni, Manuela; Santi, Daniele. - In: ACTA DIABETOLOGICA. - ISSN 0940-5429. - 60:6(2023), pp. 817-825. [10.1007/s00592-023-02073-4]
Greco, Carla; Pirotti, Tommaso; Brigante, Giulia; Filippini, Tommaso; Pacchioni, Chiara; Trenti, Tommaso; Simoni, Manuela; Santi, Daniele
File in questo prodotto:
File Dimensione Formato  
25_2023_ACTA Diabetologica_Covid & Diabetes.pdf

Accesso riservato

Descrizione: 2023_ACTA Diabetologica_Covid & Diabetes
Tipologia: Versione pubblicata dall'editore
Dimensione 889.87 kB
Formato Adobe PDF
889.87 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1300916
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact